Solid, reliable products are the core of any brand’s market competitiveness. At this major industry event, our BIOELAB booth stood out to medical specialists and business partners alike, thanks to our full lineup of upgraded instruments and years of technical know-how.
2026 Revamped BT Series Auto Chemistry Analyzers, we’ve added an optional ISE module to this upgraded line, giving labs two flexible workflow options: biochemistry-only testing, or combined biochemistry + ISE analysis. Our proprietary Intelligent-Sampling system enables direct whole blood HbA1c testing. It’s intuitive to operate and delivers consistent, precise test results.
Our first self-developed full-auto chemiluminescence unit takes up less than 1 square meter of lab space, packing high performance into a tiny footprint. Operators can top up reagents and load patient samples without pausing ongoing test runs. Multi-round magnetic washing ensures efficient B/F separation, covering all routine clinical testing requirements.
Our brand-new EC-615 model is built for micro-volume blood testing. Its compact body simplifies placement in all kinds of labs, with straightforward operation and low daily maintenance costs to fit diverse clinical settings.
Equipped with our original dynamic light source enhancement technology, the machine automatically picks the ideal detection wavelength according to sample conditions. Intelligent anti-interference algorithms guarantee excellent sensitivity. The pull-out sample rack allows continuous replenishment of all consumables mid-run, cutting down lab waiting time significantly.
Many brands in this industry tend to copy existing designs, but BIOELAB has always stuck to independent, in-depth product development. We’ve focused on continuous R&D in in vitro diagnostics to launch truly original, innovative devices that fill real market gaps.
Traffic was high on CMEF’s opening day; crowds of visitors flocked to our booth. Long-term clients and new prospects were drawn to our booth layout and premium equipment, stopping to ask detailed questions and discuss potential cooperation.
We gathered frontline market insights, tracked emerging industry trends and learned which technical features labs need most. While locking in new partnerships on site, our sales team also collected genuine user demands to guide our future R&D roadmap, supporting our expansion into broader markets.
This year’s CMEF brought together IVD practitioners from all over the world. We welcomed groups of buyers from Southeast Asia, South America, South Africa and more, holding face-to-face exchanges around diagnostic technology, product innovation and regional market demand.
Against the backdrop of global supply chain shifts, BIOELAB has doubled down on domestic market growth while steadily expanding overseas reach. We’re shifting our development focus from simple product export to full brand internationalization, bringing trusted Chinese diagnostic solutions to global healthcare systems.
Moving forward, BIOELAB will keep pace with worldwide medical industry evolution. We will rely on strict quality control to build sustainable competitive advantages, steer clear of generic, homogenized low-end products, and keep innovating high-quality diagnostic equipment. We aim to deliver steady professional support for better global medical safety.
